PH vs EMR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 21, 2026

PH

38.9
AI Score
VS
EMR Wins

EMR

49.3
AI Score

Investment Advisor Scores

PH

39score
Recommendation
SELL

EMR

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PH EMR Winner
Forward P/E 29.6736 21.9298 EMR
PEG Ratio 3.4891 1.8186 EMR
Revenue Growth 9.8% 7.0% PH
Earnings Growth 19.3% 23.0% EMR
Tradestie Score 38.9/100 49.3/100 EMR
Profit Margin 17.0% 13.8% PH
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD EMR

Relative Price Performance (Last 90 Days)

PH 1M: +1.6% · 3M: +15.8% EMR 1M: +8.5% · 3M: +16.6%

Current Technical Phase

PH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.1 · Price: $1001.74

EMR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.3% over 20 days), RSI 55

RSI (14): 55.0 · Price: $157.26

Fundamentals Snapshot

Metric PH EMR
Market Cap
Forward P/E 29.2 21.7
Trailing P/E 36.6 34.5
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.4% 0.5%
Operating Margin 0.2% 0.3%
EPS 27.93 4.49
Dividend Yield 0.01% 0.01%

Frequently Asked Questions

Based on our detailed analysis, EMR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.